InventHelp Inventor Develops Hot/Cold Therapy Cap for the Head & Neck (MHO-686)
InventHelp Inventor Develops Hot/Cold Therapy Cap for the Head & Neck (MHO-686)
PR Newswire
PITTSBURGH, Oct. 7, 2026
PITTSBURGH, Oct. 7, 2026 /PRNewswire/ -- "I wanted to create a cap accessory to provide hot and cold therapy for the head and neck," said an inventor, from Oak Harbor, Wash., "so I invented the NEURO CAP. The versatility and targeted comfort of my design make it ideal for managing neurological symptoms, migraines, and stress-related tension."

The patent-pending invention provides an improved way to address chronic pain and inflammation in the head and neck. In doing so, it offers effective hot and cold therapy for these sensitive areas, and it allows for targeted pain management. As a result, it offers an alternative to traditional hot and cold therapy products that focus solely on joints. The invention features a flexible design that is easy to wear and use so it is ideal for individuals with Multiple Sclerosis, migraines, or tension headaches.
The original design was submitted to the National sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 25-MHO-686, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

SOURCE InventHelp
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Sell for Tax-Loss Harvesting
33 Undervalued Stocks to Buy Before the Market Shifts Again
Ask the Analyst: What Is the Best Source for Low-Risk Tax-Free Income?
What’s Ahead for Stocks This Quarter—and Where to Invest
